Showing results (131-140 of 27,651) with videos related to

Sort By:
Pageof 2,766
Vaccine|July 28, 2022
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccinationKristin Goddard, Ned Lewis, Bruce Fireman, et al.
Vaccine|April 20, 2022
Ask Me Anything": Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jailsParsa Erfani, Raquel Sofia Sandoval, Katherine M Rich, et al.
Vaccine|June 6, 2019
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) studyChristopher A Bell, Margaret L Russell, Steven J Drews, et al.
Vaccine|June 6, 2019
Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D geneJemima Beissbarth, Heidi Carol Smith-Vaughan, Tegan Maree Harris, et al.
Vaccine|July 20, 2010
Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in miceJoseph N Brewoo, Tim D Powell, Dan T Stinchcomb, et al.
Vaccine|June 22, 2010
Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicumFeng Wei, Yujia Zhai, Hongtao Jin, et al.
Vaccine|July 6, 2010
Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant virusesJ Keawcharoen, M I J Spronken, O Vuong, et al.
Vaccine|July 6, 2010
A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteersHee-Chang Jang, Choong Jong Kim, Kye Hyoung Kim, et al.
Vaccine|July 6, 2010
Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in JapanMegumi Hara, Keitaro Tanaka, Tetsuo Kase, et al.
Vaccine|July 6, 2010
Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)Nicolas Goulleret, Elodie Mauvisseau, Mélanie Essevaz-Roulet, et al.
Pageof 2,766